President Donald Trump’s push for lower US drug prices has unexpectedly helped Astellas Pharma Inc. secure higher reimbursement pricing for its new eye medicine in Japan.
Latest posts by Toimitus (see all)
Protesters clash with police in Kenya as they march against a US-run Ebola quarantine centre …